A new study published in the journal of Diabetes Research and Clinical Practice found that patients with type 1 and type 2 ...

EyePoint Pharmaceuticals' Duravyu shows promising Phase 2 results in DME, with potential for less frequent dosing. Check out ...

A pop-up diabetic eye screening clinic held at Bentley Pavilion has helped 36 local residents take an important step in ...

Disorganization of retinal inner layers (DRIL) is likely an important biomarker signaling visual deterioration in patients with diabetic macular ischemia (DMI), and overall causes for functional ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Investigators examined GLP-1 receptor agonist real-world effectiveness and safety in kidney transplant recipients with diabetes.

A new study found a link between GLP-1s and a higher risk of neovascular age-related macular degeneration, an eye disease ...

LAS VEGAS, NEVADA / ACCESS Newswire / June 10, 2025 / Avant Technologies Inc. (OTCQB:AVAI) (“Avant” or the “Company”), and ...

Current technologies, and those in the pipeline and beyond, could advance the management of diabetes comorbidities, George Grunberger, MD, FACP, FACE, said during a presentation at the Heart in ...

Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing ...

HealthDay News — For patients with diabetes, exposure to glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with an increased risk for incident neovascular age-related macular ...

Spain Although the prevalence of all stages of diabetic retinopathy has been declining since 1980 in populations with improved diabetes control, the crude prevalence of visual impairment and blindness ...